Loading clinical trials...
Loading clinical trials...
A Clinical Applied Study on the Impact of Different Early Protein Supplementation Levels on the Prognosis of Neurocritical Patients
Conditions
Interventions
Low-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
Moderate-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
+1 more
Start Date
December 1, 2025
Primary Completion Date
June 1, 2028
Completion Date
October 1, 2028
Last Updated
December 19, 2025
NCT07371455
NCT07253181
NCT06990867
NCT07001267
NCT04521881
NCT07455136
Lead Sponsor
Wenshan City People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions